Cargando…
Ganglioside GM3 Is Antiangiogenic in Malignant Brain Cancer
Progression of malignant brain tumors is dependent upon vascularity and is associated with altered ganglioside composition and distribution. Evidence is reviewed showing that the simple monosialoganglioside, GM3, possesses powerful antiangiogenic action against the highly vascularized CT-2A mouse as...
Autores principales: | Seyfried, Thomas N., Mukherjee, Purna |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904445/ https://www.ncbi.nlm.nih.gov/pubmed/20634908 http://dx.doi.org/10.1155/2010/961243 |
Ejemplares similares
-
Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review
por: Zhang, Wenchao, et al.
Publicado: (2019) -
Physiopathological function of hematoside (GM3 ganglioside)
por: INOKUCHI, Jin-ichi
Publicado: (2011) -
Targeting energy metabolism in brain cancer: review and hypothesis
por: Seyfried, Thomas N, et al.
Publicado: (2005) -
NGcGM3 Ganglioside: A Privileged Target for Cancer Vaccines
por: Fernandez, Luis E., et al.
Publicado: (2010) -
The relationship between depletion of brain GM1 ganglioside and Parkinson's disease
por: Sonnino, Sandro
Publicado: (2023)